世界のクエチアピンフマル酸塩販売市場2021

QYResearchが発行した調査報告書(QYR21JN7867)
◆英語タイトル:Global Quetiapine Fumarate Sales Market Report 2021
◆商品コード:QYR21JN7867
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月6日(※2024年版があります。お問い合わせください。)
◆ページ数:140
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のクエチアピンフマル酸塩市場について種類別(即時放出錠、徐放錠)、用途別(大人、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・クエチアピンフマル酸塩市場の概要
・世界の主要地域別クエチアピンフマル酸塩市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のクエチアピンフマル酸塩市場規模2016-2021:種類別(即時放出錠、徐放錠)
・世界のクエチアピンフマル酸塩市場予測2012-2027:種類別(即時放出錠、徐放錠)
・世界のクエチアピンフマル酸塩市場規模2016-2021:用途別(大人、その他)
・世界のクエチアピンフマル酸塩市場予測2012-2027:用途別(大人、その他)
・クエチアピンフマル酸塩のアメリカ市場規模と予測2016-2021
・クエチアピンフマル酸塩のヨーロッパ市場規模と予測2016-2021
・クエチアピンフマル酸塩の中国市場規模と予測2016-2021
・クエチアピンフマル酸塩の日本市場規模と予測2016-2021
・クエチアピンフマル酸塩の東南アジア市場規模と予測2016-2021
・クエチアピンフマル酸塩のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(AstraZeneca、Intas、TAPI、Accord、Hexal、Dr.Reddy's、Lupin、Sun Pharmaceutical、Hunan Dongting Pharm、SuZhou NO.4 Phamaceutical Factory、Fuan Pharmaceutical、Zhejiang Supor Pharmaceuticals、Zhejiang Huahai Pharmaceutical)
・クエチアピンフマル酸塩の製造コスト分析
・販売チャネル、流通業者、顧客
・クエチアピンフマル酸塩の市場動向・機会・課題
・調査の結論
【レポートの概要】

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The Quetiapine Fumarate was developed by AstraZeneca from 1992 to 1996. It was first approved by the FDA in 1997.

Market Analysis and Insights: Global Quetiapine Fumarate Market
The global Quetiapine Fumarate market was valued at US$ 159.7 in 2020 and will reach US$ 139.8 million by the end of 2027, growing at a CAGR of -2.2% during 2022-2027.

Global Quetiapine Fumarate Scope and Market Size
The global Quetiapine Fumarate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Quetiapine Fumarate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Immediate Release Tablets
Extended Release Tablets

Segment by Application
Adult
Others

The Quetiapine Fumarate market is analysed and market size information is provided by regions (countries). Segment by Application, the Quetiapine Fumarate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy’s
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical

【レポートの目次】

1 Quetiapine Fumarate Market Overview
1.1 Quetiapine Fumarate Product Scope
1.2 Quetiapine Fumarate Segment by Type
1.2.1 Global Quetiapine Fumarate Sales by Type (2016 & 2021 & 2027)
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Quetiapine Fumarate Segment by Application
1.3.1 Global Quetiapine Fumarate Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Adult
1.3.3 Others
1.4 Quetiapine Fumarate Market Estimates and Forecasts (2016-2027)
1.4.1 Global Quetiapine Fumarate Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Quetiapine Fumarate Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Quetiapine Fumarate Price Trends (2016-2027)

2 Quetiapine Fumarate Estimates and Forecasts by Region
2.1 Global Quetiapine Fumarate Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Quetiapine Fumarate Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Quetiapine Fumarate Sales Market Share by Region (2016-2021)
2.2.2 Global Quetiapine Fumarate Revenue Market Share by Region (2016-2021)
2.3 Global Quetiapine Fumarate Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Quetiapine Fumarate Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Quetiapine Fumarate Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Quetiapine Fumarate Estimates and Projections (2016-2027)
2.4.2 Europe Quetiapine Fumarate Estimates and Projections (2016-2027)
2.4.3 China Quetiapine Fumarate Estimates and Projections (2016-2027)
2.4.4 Japan Quetiapine Fumarate Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Quetiapine Fumarate Estimates and Projections (2016-2027)
2.4.6 India Quetiapine Fumarate Estimates and Projections (2016-2027)
3 Global Quetiapine Fumarate Competition Landscape by Players
3.1 Global Top Quetiapine Fumarate Players by Sales (2016-2021)
3.2 Global Top Quetiapine Fumarate Players by Revenue (2016-2021)
3.3 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2020)
3.4 Global Quetiapine Fumarate Average Price by Company (2016-2021)
3.5 Manufacturers Quetiapine Fumarate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Quetiapine Fumarate Market Size by Type
4.1 Global Quetiapine Fumarate Historic Market Review by Type (2016-2021)
4.1.1 Global Quetiapine Fumarate Sales Market Share by Type (2016-2021)
4.1.2 Global Quetiapine Fumarate Revenue Market Share by Type (2016-2021)
4.1.3 Global Quetiapine Fumarate Price by Type (2016-2021)
4.2 Global Quetiapine Fumarate Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Quetiapine Fumarate Sales Forecast by Type (2022-2027)
4.2.2 Global Quetiapine Fumarate Revenue Forecast by Type (2022-2027)
4.2.3 Global Quetiapine Fumarate Price Forecast by Type (2022-2027)
5 Global Quetiapine Fumarate Market Size by Application
5.1 Global Quetiapine Fumarate Historic Market Review by Application (2016-2021)
5.1.1 Global Quetiapine Fumarate Sales Market Share by Application (2016-2021)
5.1.2 Global Quetiapine Fumarate Revenue Market Share by Application (2016-2021)
5.1.3 Global Quetiapine Fumarate Price by Application (2016-2021)
5.2 Global Quetiapine Fumarate Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Quetiapine Fumarate Sales Forecast by Application (2022-2027)
5.2.2 Global Quetiapine Fumarate Revenue Forecast by Application (2022-2027)
5.2.3 Global Quetiapine Fumarate Price Forecast by Application (2022-2027)

6 North America Quetiapine Fumarate Market Facts & Figures
6.1 North America Quetiapine Fumarate Sales by Company
6.1.1 North America Quetiapine Fumarate Sales by Company (2016-2021)
6.1.2 North America Quetiapine Fumarate Revenue by Company (2016-2021)
6.2 North America Quetiapine Fumarate Sales Breakdown by Type
6.2.1 North America Quetiapine Fumarate Sales Breakdown by Type (2016-2021)
6.2.2 North America Quetiapine Fumarate Sales Breakdown by Type (2022-2027)
6.3 North America Quetiapine Fumarate Sales Breakdown by Application
6.3.1 North America Quetiapine Fumarate Sales Breakdown by Application (2016-2021)
6.3.2 North America Quetiapine Fumarate Sales Breakdown by Application (2022-2027)

7 Europe Quetiapine Fumarate Market Facts & Figures
7.1 Europe Quetiapine Fumarate Sales by Company
7.1.1 Europe Quetiapine Fumarate Sales by Company (2016-2021)
7.1.2 Europe Quetiapine Fumarate Revenue by Company (2016-2021)
7.2 Europe Quetiapine Fumarate Sales Breakdown by Type
7.2.1 Europe Quetiapine Fumarate Sales Breakdown by Type (2016-2021)
7.2.2 Europe Quetiapine Fumarate Sales Breakdown by Type (2022-2027)
7.3 Europe Quetiapine Fumarate Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8 China Quetiapine Fumarate Market Facts & Figures
8.1 China Quetiapine Fumarate Sales by Company
8.1.1 China Quetiapine Fumarate Sales by Company (2016-2021)
8.1.2 China Quetiapine Fumarate Revenue by Company (2016-2021)
8.2 China Quetiapine Fumarate Sales Breakdown by Type
8.2.1 China Quetiapine Fumarate Sales Breakdown by Type (2016-2021)
8.2.2 China Quetiapine Fumarate Sales Breakdown by Type (2022-2027)
8.3 China Quetiapine Fumarate Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)

9 Japan Quetiapine Fumarate Market Facts & Figures
9.1 Japan Quetiapine Fumarate Sales by Company
9.1.1 Japan Quetiapine Fumarate Sales by Company (2016-2021)
9.1.2 Japan Quetiapine Fumarate Revenue by Company (2016-2021)
9.2 Japan Quetiapine Fumarate Sales Breakdown by Type
9.2.1 Japan Quetiapine Fumarate Sales Breakdown by Type (2016-2021)
9.2.2 Japan Quetiapine Fumarate Sales Breakdown by Type (2022-2027)
9.3 Japan Quetiapine Fumarate Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Quetiapine Fumarate Market Facts & Figures
10.1 Southeast Asia Quetiapine Fumarate Sales by Company
10.1.1 Southeast Asia Quetiapine Fumarate Sales by Company (2016-2021)
10.1.2 Southeast Asia Quetiapine Fumarate Revenue by Company (2016-2021)
10.2 Southeast Asia Quetiapine Fumarate Sales Breakdown by Type
10.2.1 Southeast Asia Quetiapine Fumarate Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Quetiapine Fumarate Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Quetiapine Fumarate Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Quetiapine Fumarate Market Facts & Figures
11.1 India Quetiapine Fumarate Sales by Company
11.1.1 India Quetiapine Fumarate Sales by Company (2016-2021)
11.1.2 India Quetiapine Fumarate Revenue by Company (2016-2021)
11.2 India Quetiapine Fumarate Sales Breakdown by Type
11.2.1 India Quetiapine Fumarate Sales Breakdown by Type (2016-2021)
11.2.2 India Quetiapine Fumarate Sales Breakdown by Type (2022-2027)
11.3 India Quetiapine Fumarate Sales Breakdown by Application
11.3.1 India Quetiapine Fumarate Sales Breakdown by Application (2016-2021)
11.3.2 India Quetiapine Fumarate Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Quetiapine Fumarate Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Quetiapine Fumarate Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Intas
12.2.1 Intas Corporation Information
12.2.2 Intas Business Overview
12.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Intas Quetiapine Fumarate Products Offered
12.2.5 Intas Recent Development
12.3 TAPI
12.3.1 TAPI Corporation Information
12.3.2 TAPI Business Overview
12.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.3.4 TAPI Quetiapine Fumarate Products Offered
12.3.5 TAPI Recent Development
12.4 Accord
12.4.1 Accord Corporation Information
12.4.2 Accord Business Overview
12.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Accord Quetiapine Fumarate Products Offered
12.4.5 Accord Recent Development
12.5 Hexal
12.5.1 Hexal Corporation Information
12.5.2 Hexal Business Overview
12.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hexal Quetiapine Fumarate Products Offered
12.5.5 Hexal Recent Development
12.6 Dr.Reddy’s
12.6.1 Dr.Reddy’s Corporation Information
12.6.2 Dr.Reddy’s Business Overview
12.6.3 Dr.Reddy’s Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dr.Reddy’s Quetiapine Fumarate Products Offered
12.6.5 Dr.Reddy’s Recent Development
12.7 Lupin
12.7.1 Lupin Corporation Information
12.7.2 Lupin Business Overview
12.7.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Lupin Quetiapine Fumarate Products Offered
12.7.5 Lupin Recent Development
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Corporation Information
12.8.2 Sun Pharmaceutical Business Overview
12.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sun Pharmaceutical Quetiapine Fumarate Products Offered
12.8.5 Sun Pharmaceutical Recent Development
12.9 Hunan Dongting Pharm
12.9.1 Hunan Dongting Pharm Corporation Information
12.9.2 Hunan Dongting Pharm Business Overview
12.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
12.9.5 Hunan Dongting Pharm Recent Development
12.10 SuZhou NO.4 Phamaceutical Factory
12.10.1 SuZhou NO.4 Phamaceutical Factory Corporation Information
12.10.2 SuZhou NO.4 Phamaceutical Factory Business Overview
12.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
12.10.5 SuZhou NO.4 Phamaceutical Factory Recent Development
12.11 Fuan Pharmaceutical
12.11.1 Fuan Pharmaceutical Corporation Information
12.11.2 Fuan Pharmaceutical Business Overview
12.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Fuan Pharmaceutical Quetiapine Fumarate Products Offered
12.11.5 Fuan Pharmaceutical Recent Development
12.12 Zhejiang Supor Pharmaceuticals
12.12.1 Zhejiang Supor Pharmaceuticals Corporation Information
12.12.2 Zhejiang Supor Pharmaceuticals Business Overview
12.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Products Offered
12.12.5 Zhejiang Supor Pharmaceuticals Recent Development
12.13 Zhejiang Huahai Pharmaceutical
12.13.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.13.2 Zhejiang Huahai Pharmaceutical Business Overview
12.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Products Offered
12.13.5 Zhejiang Huahai Pharmaceutical Recent Development

13 Quetiapine Fumarate Manufacturing Cost Analysis
13.1 Quetiapine Fumarate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Quetiapine Fumarate
13.4 Quetiapine Fumarate Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Quetiapine Fumarate Distributors List
14.3 Quetiapine Fumarate Customers

15 Market Dynamics
15.1 Quetiapine Fumarate Market Trends
15.2 Quetiapine Fumarate Drivers
15.3 Quetiapine Fumarate Market Challenges
15.4 Quetiapine Fumarate Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のクエチアピンフマル酸塩販売市場2021(Global Quetiapine Fumarate Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。